These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26197777)

  • 1. Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST).
    Saito O; Kusano E; Akimoto T; Asano Y; Kitagawa T; Suzuki K; Ishige N; Akiba T; Saito A; Ishimura E; Hattori M; Hishida A; Guili C; Maruyama H; Kobayashi M; Ohashi T; Matsuda I; Eto Y
    Clin Exp Nephrol; 2016 Apr; 20(2):284-93. PubMed ID: 26197777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients.
    Nishino T; Obata Y; Furusu A; Hirose M; Shinzato K; Hattori K; Nakamura K; Matsumoto T; Endo F; Kohno S
    Ren Fail; 2012; 34(5):566-70. PubMed ID: 22563919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
    Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ
    Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of screening for Fabry disease among male dialysis patients.
    Ichinose M; Nakayama M; Ohashi T; Utsunomiya Y; Kobayashi M; Eto Y
    Clin Exp Nephrol; 2005 Sep; 9(3):228-32. PubMed ID: 16189631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Fabry disease in male patients with end-stage renal disease in western France.
    Vigneau C; Germain DP; Larmet D; Jabbour F; Hourmant M;
    Nephrol Ther; 2021 Jun; 17(3):180-184. PubMed ID: 33994139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Fabry disease among Turkish dialysis patients: Data from hemodialysis centers in Bursa province.
    Sayilar EI; Ayar Y; Yavuz M
    Clin Nephrol; 2016 Mar; 85(3):165-72. PubMed ID: 26833297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of Fabry Disease Screening in Male Pre-End Stage Renal Disease Patients with Unknown Etiology Found Through the Platform of a Chronic Kidney Disease Education Program in a Northern Taiwan Medical Center.
    Lin CJ; Chien YH; Lai TS; Shih HM; Chen YC; Pan CF; Chen HH; Hwu WL; Wu CJ
    Kidney Blood Press Res; 2018; 43(5):1636-1645. PubMed ID: 30380558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of male dialysis patients for fabry disease by plasma globotriaosylsphingosine.
    Maruyama H; Takata T; Tsubata Y; Tazawa R; Goto K; Tohyama J; Narita I; Yoshioka H; Ishii S
    Clin J Am Soc Nephrol; 2013 Apr; 8(4):629-36. PubMed ID: 23307880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report.
    Porsch DB; Nunes AC; Milani V; Rossato LB; Mattos CB; Tsao M; Netto C; Burin M; Pereira F; Matte U; Giugliani R; Barros EJ
    Ren Fail; 2008; 30(9):825-30. PubMed ID: 18925518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
    Ortiz A; Cianciaruso B; Cizmarik M; Germain DP; Mignani R; Oliveira JP; Villalobos J; Vujkovac B; Waldek S; Wanner C; Warnock DG
    Nephrol Dial Transplant; 2010 Mar; 25(3):769-75. PubMed ID: 19846394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke.
    Dubuc V; Moore DF; Gioia LC; Saposnik G; Selchen D; Lanthier S
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1288-92. PubMed ID: 23168217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of Fabry disease with the E66Q variant in the α-galactosidase A gene in Japanese dialysis patients: a case report and a literature review.
    Kikumoto Y; Sugiyama H; Morinaga H; Inoue T; Takiue K; Kitagawa M; Saito D; Takatori Y; Kinomura M; Kitamura S; Akagi S; Sada K; Nakao K; Maeshima Y; Kitayama H; Makino H
    Clin Nephrol; 2012 Sep; 78(3):224-9. PubMed ID: 22874111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-galactosidase A activity levels in Turkish male hemodialysis patients.
    Kalkan Uçar S; Sozmen E; Duman S; Başçi A; Çoker M
    Ther Apher Dial; 2012 Dec; 16(6):560-5. PubMed ID: 23190516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry disease.
    Linthorst GE; Hollak CE; Korevaar JC; Van Manen JG; Aerts JM; Boeschoten EW
    Nephrol Dial Transplant; 2003 Aug; 18(8):1581-4. PubMed ID: 12897098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study.
    Jahan S; Sarathchandran S; Akhter S; Goldblatt J; Stark S; Crawford D; Mallett A; Thomas M
    Orphanet J Rare Dis; 2020 Jan; 15(1):10. PubMed ID: 31931840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening.
    Silva CA; Barreto FC; Dos Reis MA; Moura Junior JA; Cruz CM
    Nephron; 2016; 134(4):221-230. PubMed ID: 27576502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of Fabry disease in patients with chronic kidney disease in Japan.
    Nagata A; Nasu M; Kaida Y; Nakayama Y; Kurokawa Y; Nakamura N; Shibata R; Hazama T; Tsukimura T; Togawa T; Saito S; Sakuraba H; Fukami K
    Nephrol Dial Transplant; 2021 Dec; 37(1):115-125. PubMed ID: 34282462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.
    Kotanko P; Kramar R; Devrnja D; Paschke E; Voigtländer T; Auinger M; Pagliardini S; Spada M; Demmelbauer K; Lorenz M; Hauser AC; Kofler HJ; Lhotta K; Neyer U; Pronai W; Wallner M; Wieser C; Wiesholzer M; Zodl H; Födinger M; Sunder-Plassmann G
    J Am Soc Nephrol; 2004 May; 15(5):1323-9. PubMed ID: 15100373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test.
    Andrade J; Waters PJ; Singh RS; Levin A; Toh BC; Vallance HD; Sirrs S
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):139-45. PubMed ID: 18003767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the α-galactosidase A gene.
    Kobayashi M; Ohashi T; Fukuda T; Yanagisawa T; Inomata T; Nagaoka T; Kitagawa T; Eto Y; Ida H; Kusano E
    Mol Genet Metab; 2012 Dec; 107(4):711-5. PubMed ID: 23146289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.